1. Jean-Nicholas Mess obtained his master’s degree in biochemistry from the University of Montréal (QC, Canada) in 2004 and joined Algorithme Pharma (QC, Canada) as a Method Development Scientist. Over the years, he has actively participated in the publication of multiple peer-reviewed papers on bioanalytical method development by LC–MS. In his new role as Scientific Advisor for new molecular entities (preclinical and Phase I studies), he is now focusing on developing the field of large-molecule bioanalysis...
2. France Landry holds a postgraduate master’s degree in biomedical sciences from the University of Montréal. She is a Principal Scientist in the Method Development Group at Algorithme Pharma. She has a scientific background from academia and the pharmaceutical industry in the preclinical and clinical environment. She has extensive experience in biology and biochemistry using chromatography and MS for small molecules, peptides, proteins and lipid analysis.
3. Fabio Garofolo has been working in the pharmaceutical and analytical fields for more than 22 years. Capitalizing on an extensive occupational background within his specialization field, he has also been involved in helping scientific nonprofit organizations to promote discussion on pharmaceutical practices. He has progressed throughout in his career in both the pharma/biotech and CRO industries and benefited from successfully overcoming the prevalent challenges in drug development. Since 2005, he has...